PHAR Pharming: Earnings per share for the last twelve months
The business foundation of Pharming Group N.V. (PHAR) relies on Dutch capacities and successful sales of orphan drugs. The fundamental TTM net income per share metric visualizes the actual earnings of each share, where 0.32 indicates the current level. Despite geopolitical risks regarding supplies and patents, the company's strategy targets global portfolio expansion while maintaining a stable cash flow.
Analytical breakdowns and data insights for company Pharming Corp (PHAR)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Pharming Group N.V.|PHAR - Long-Term Liabilities to Capital|Short-Term Debt to Equity Pharming|PHAR - Company Aggregate Indebtedness|Debts to Book Capitalization Pharming Corp|PHAR - Company Long-Term Loans and Borrowings|Company Short-Term Debts Pharming Group|Quick Liquidity pharming.com
- earnings and valuation multiples indicators:
PHAR - Final Profit|Expected Profit Pharming Group N.V.|PHAR - Price to Earnings Ratio|Forward P/E Multiple Pharming Corp|PHAR - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming Group|PHAR - Operating profit before amortization|Net earnings per share (EPS TTM) Pharming Group|PHAR - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months pharming.com|PHAR - Earnings per share increase in current year|Earnings growth forecast for next year Pharming Group N.V.
- sales and revenue data:
Summary company analysis:Pharming Group (PHAR)
To minimize risks when establishing a long-term position, one should evaluate the rolling annual net profit, which offsets quarterly gaps and reflects the actual earnings per share. By analyzing the 12-month net income per share trend, an investor can see how the expansion of Pharming Group N.V. (PHAR) across US and European markets strengthens the business's fundamental stability through sales diversification.
Competing companies
ARGX - Earnings per share for the last twelve months|BioNTech Inc. (BNTX) - Net earnings per share for the last 12 months|abivax.com (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) immunovant.com|Earnings per share for the last twelve months Kiniksa Pharmaceuticals Ltd (KNSA)|Grifols - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (adaptivebiotech.com)|Celldex (CLDX) - Net earnings per one share for the last twelve months|Aurinia Corp - Net earnings per share (EPS TTM)|BCRX: Earnings per share for the last twelve months|VERA: Net earnings per share (EPS TTM)|DNTH - Net earnings per share for the last four quarters|PHVS (Pharvaris NV) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months AbCellera Corp (ABCL)|Earnings per share for the last twelve months Tourmaline Bio, Inc. (TRML)|Net earnings per share for the last 12 months Precigen, Inc. PGEN|Net earnings per share (EPS TTM) NKTR (nektar.com)|Upstream Bio (UPB) - Net earnings per one share for the last twelve months|ZBIO: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Immunome Bio|GOSS: Net earnings per share (EPS TTM)|KALV: Earnings per share for the last four quarters|SEPN (septerna.com) - Net earnings per share (EPS TTM)|Pieris Pharmaceuticals, Inc. - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Savara Inc. (SVRA)|Net earnings per share (EPS TTM) Rigel Corp (RIGL)|Earnings per share for the last twelve months AnaptysBio Inc ANAB|astriatx.com (ATXS) - Net earnings per one share for the last twelve months|enGene Bio - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RAPT|JBIO: Net earnings per share (EPS TTM)|Aclaris - Earnings per share for the trailing year|KYTX (Kyverna Therapeutics, Inc) - Net earnings per share (EPS TTM)|TLSA: Earnings per share for the trailing year|Net earnings per share for the last 12 months CABA (Cabaletta Bio)|VTYX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) THTX (Theratechnologies, Inc)|Earnings per share for the last four quarters AVTX (Avalo Therapeutics Inc.)|ELDN: Net earnings per share for the last 12 months|AGEN - Net earnings per share (EPS TTM)|Climb Bio Inc. (CLYM) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ZURA (Zura Bio)|Net earnings per share for the last 12 months ATYR|ADAG: Earnings per share for the trailing year|Net earnings per share (EPS TTM) IMA|Net earnings per share for the last four quarters Shattuck Therapeutics|Net earnings per share (EPS TTM) EQ (Equillium Inc)|Earnings per share for the last four quarters CNTB (Connect Pharma)|IMUX - Earnings per share for the last twelve months|Net earnings per share for the last four quarters atarabio.com ATRA|IFRX: Net earnings per share (EPS TTM)|XFOR (X4 Pharmaceuticals, Inc) - Earnings per share for the last twelve months|Earnings per share for the last twelve months adicetbio.com|CELU: Earnings per share for the trailing year|Earnings per share for the last twelve months INmune Bio Corporation (INMB)|Net earnings per share for the last 12 months Barinthus Biotherapeutics Corp BRNS|Earnings per share for the last twelve months Kezar Life Sciences KZR|Earnings per share for the trailing year SABS|AKTX - Earnings per share for the last twelve months|Earnings per share for the trailing year ENLV (enlivex.com)|Q32 Bio Inc. (QTTB) - Earnings per share for the last twelve months|GeoVax Labs Inc - Earnings per share for the trailing year|EDSA (Edesa Biotech Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months IBIO|Earnings per share for the last twelve months Carisma Therapeutics Inc (CARM)|Net earnings per share (EPS TTM) XTL Biopharmaceuticals Ltd (XTLB)|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics Inc.)|Net earnings per share for the last four quarters HCW Biologics Inc. (HCWB)|Aptevo Therapeutics, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters aimimmuno.com AIM|ADTX (aditxt.com) - Net earnings per share for the last 12 months|GRI (GRI Bio) - Earnings per share for the last twelve months|XRTX (XORTX Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Vyome Therapeutics|Net earnings per share (EPS TTM) REVB|Net earnings per share for the last 12 months indaptusrx.com INDP|Net earnings per share (EPS TTM) SCNI (scinai.com)|Net earnings per share (EPS TTM) CalciMedica, Inc. CALI|AFMD - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Allakos Inc ALLK|HOOK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months IGM Biosciences Inc. (IGMS)|ITOS (iTeos Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ocean Biomedical Inc OCEA|Earnings per share for the last twelve months TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio, Inc) - Earnings per share for the trailing year
